Apr 16, 2017
Venetoclax - an inhibitor of the anti-apoptosis B-cell lymphoma-2 (Bcl-2) protein, and leading to cell death, for the treatment of chronic lymphocytic leukaemia, including ones with the 17p deletion genetic mutation.
Loading...
seen from China
seen from United States
seen from United States
seen from United States
seen from United States
seen from Moldova
seen from Moldova
seen from United States
seen from Moldova
seen from Canada
seen from Singapore
seen from China
seen from United States
seen from Moldova
seen from United States
seen from United States
seen from United States
seen from Australia
seen from Malaysia
seen from Sweden
Venetoclax - an inhibitor of the anti-apoptosis B-cell lymphoma-2 (Bcl-2) protein, and leading to cell death, for the treatment of chronic lymphocytic leukaemia, including ones with the 17p deletion genetic mutation.
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
New Post has been published on Abbkine - Your life science partner
Bcl-2 Polyclonal Antibody Review
BCL2 (B-cell leukemia/lymphoma 2, N-Histidine-tagged), also known as Bcl-2, belongs to the Bcl-2 family. Bcl-2 family proteins regulate and contribute to programmed cell death or apoptosis. It is a large protein family and all members contain at least one of four BH (bcl-2 homology) domains. Certain members such as Bcl-2, Bcl-xl and Mcl1 are anti-apoptotic, whilst others are pro-apoptotic. Most Bcl-2 family members contain a C-terminal transmembrane domain that functions to target these proteins to the outer mitochondrial and other intracellular membranes. It is expressed in a variety of tissues. BCL2 blocks the apoptotic death of some cells such as lymphocytes. It also regulates cell death by controlling the mitochondrial membrane permeability and inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants, produced by alternate splicing, differ in their C-terminal ends.
Bcl-2 Polyclonal Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody has been tested with WB and ELISA. And Abbkine suggested starting dilutions are as follows: WB: 1:500-2000, ELISA 1：10000-20000.
BCL2(BCL2, apoptosis regulator)encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. The quality of Bcl-2 Polyclonal Antibody is found satisfactory. Thanks a lot for the help of your company!
New Post has been published on Abbkine - Your life science partner
New Post has been published on http://www.abbkine.com/bcl-2-polyclonal-antibody-review/
Bcl-2 Polyclonal Antibody Review
BCL2 (B-cell leukemia/lymphoma 2, N-Histidine-tagged), also known as Bcl-2, belongs to the Bcl-2 family. Bcl-2 family proteins regulate and contribute to programmed cell death or apoptosis. It is a large protein family and all members contain at least one of four BH (bcl-2 homology) domains. Certain members such as Bcl-2, Bcl-xl and Mcl1 are anti-apoptotic, whilst others are pro-apoptotic. Most Bcl-2 family members contain a C-terminal transmembrane domain that functions to target these proteins to the outer mitochondrial and other intracellular membranes. It is expressed in a variety of tissues. BCL2 blocks the apoptotic death of some cells such as lymphocytes. It also regulates cell death by controlling the mitochondrial membrane permeability and inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants, produced by alternate splicing, differ in their C-terminal ends.
Bcl-2 Polyclonal Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody has been tested with WB and ELISA. And Abbkine suggested starting dilutions are as follows: WB: 1:500-2000, ELISA 1：10000-20000.
BCL2(BCL2, apoptosis regulator)encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. The quality of Bcl-2 Polyclonal Antibody is found satisfactory. Thanks a lot for the help of your company!
New Post has been published on Abbkine - Your life science partner
Interests on http://www.abbkine.com/bcl-2-polyclonal-antibody-review/
Bcl-2 Polyclonal Antibody Review
BCL2 (B-cell leukemia/lymphoma 2, N-Histidine-tagged), also known as Bcl-2, belongs to the Bcl-2 family. Bcl-2 family proteins regulate and contribute to programmed cell death or apoptosis. It is a large protein family and all members contain at least one of four BH (bcl-2 homology) domains..... Click for moreBcl-2 Polyclonal Antibody Review.
New Post has been published on Abbkine - Your life science partner
New Post has been published on http://www.abbkine.com/bcl-2-polyclonal-antibody-review/
Bcl-2 Polyclonal Antibody Review
BCL2 (B-cell leukemia/lymphoma 2, N-Histidine-tagged), also known as Bcl-2, belongs to the Bcl-2 family. Bcl-2 family proteins regulate and contribute to programmed cell death or apoptosis. It is a large protein family and all members contain at least one of four BH (bcl-2 homology) domains. Certain members such as Bcl-2, Bcl-xl and Mcl1 are anti-apoptotic, whilst others are pro-apoptotic. Most Bcl-2 family members contain a C-terminal transmembrane domain that functions to target these proteins to the outer mitochondrial and other intracellular membranes. It is expressed in a variety of tissues. BCL2 blocks the apoptotic death of some cells such as lymphocytes. It also regulates cell death by controlling the mitochondrial membrane permeability and inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants, produced by alternate splicing, differ in their C-terminal ends.
Bcl-2 Polyclonal Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody has been tested with WB and ELISA. And Abbkine suggested starting dilutions are as follows: WB: 1:500-2000, ELISA 1：10000-20000.
BCL2(BCL2, apoptosis regulator)encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. The quality of Bcl-2 Polyclonal Antibody is found satisfactory. Thanks a lot for the help of your company!
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
New Post has been published on Abbkine - Your life science partner
New Post has been published on http://www.abbkine.com/bcl-2-polyclonal-antibody-review/
Bcl-2 Polyclonal Antibody Review
BCL2 (B-cell leukemia/lymphoma 2, N-Histidine-tagged), also known as Bcl-2, belongs to the Bcl-2 family. Bcl-2 family proteins regulate and contribute to programmed cell death or apoptosis. It is a large protein family and all members contain at least one of four BH (bcl-2 homology) domains. Certain members such as Bcl-2, Bcl-xl and Mcl1 are anti-apoptotic, whilst others are pro-apoptotic. Most Bcl-2 family members contain a C-terminal transmembrane domain that functions to target these proteins to the outer mitochondrial and other intracellular membranes. It is expressed in a variety of tissues. BCL2 blocks the apoptotic death of some cells such as lymphocytes. It also regulates cell death by controlling the mitochondrial membrane permeability and inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants, produced by alternate splicing, differ in their C-terminal ends.
Bcl-2 Polyclonal Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody has been tested with WB and ELISA. And Abbkine suggested starting dilutions are as follows: WB: 1:500-2000, ELISA 1：10000-20000.
BCL2(BCL2, apoptosis regulator)encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. The quality of Bcl-2 Polyclonal Antibody is found satisfactory. Thanks a lot for the help of your company!
Researchers identify previously unknown pathway for cell death. Thoughts health innovators? It is known that cell death is a mechanism used by multicellular organisms to help them survive by removing infected, damaged or unwanted cells.
Follicular Lymphoma
All of them are B-cell lymphomas
MOST COMMON of lymphomas
t(14:18)
18 Chromosome: bcl-2 (inhibits apoptosis)
No response to therapy, slow growing, but hard to tx
50% progress to Diffuse Large B-Cell Lymphoma
Bx: follicules in CORTEX & MEDULLA, throughout the lymph node, disruption of architecture, nodular Pattern growth.
How can I differentiate it from Follicular Hyperplasia?
Follicular hyperplasia is often seen in children as a reactive condition. Notice the multiple follicles, each with an active germinal center showing mitoses, apoptosis, and phagocytosis, surrounded by a well-defined mantle layer. A normal germinal center will show NO production of bcl-2, the anti-apoptotic protein. The follicles are separated by the interfollicular zones (T-cells).Â